title: Recurrence factors in women underwent laparoscopic surgery for endometrioma.
abstract: OBJECTIVE
  The aim of this paper was to assess the risk factors for endometrioma recurrence in women underwent laparoscopic surgery for endometrioma.
  
  
  METHODS
  This retrospective designed study included 113 cases that underwent laparoscopic surgery for endometrioma; of these women, recurrent endometrioma was detected in 33 (29.20%) subjects and other showed no recurrence (70.80%). Age, gravidity, parity, diameter of the mass, bilaterality, previous pelvic surgery, operation type, presence of adhesions, Ca 125 levels and recurrence time was obtained from hospital records and special gynecology forms.
  
  
  RESULTS
  Demographic and obstetric past history of the cases showed no statistically significant difference between the groups (P>0.05). Higher diameter of the mass, previous pelvic surgery, operation type, presence of adhesion and higher Ca 125 levels were risk factors for endometrioma recurrence (P<0.05). Receiver operator curve (ROC) analysis demonstrated that diameter of the mass, previous pelvic surgery and Ca 125 levels may be discriminative risk factors for endometrioma recurrence.
  
  
  CONCLUSIONS
  Endometriomas ≥ 4.5 cm, especially in cases with pelvic adhesions, previous pelvic surgery and higher Ca 125 levels should be excised totally.
authors.affiliation: Zekai Tahir Burak Women's Health Education and Research Hospital Ankara, Turkey - aliirfanguzel77@gmail.com.
authors.forename: A I
authors.initials: AI
authors.lastname: Guzel
authors.forename: H O
authors.initials: HO
authors.lastname: Topcu
authors.forename: S
authors.initials: S
authors.lastname: Ekilinc
authors.forename: A
authors.initials: A
authors.lastname: Tokmak
authors.forename: M K
authors.initials: MK
authors.lastname: Kokanali
authors.forename: S
authors.initials: S
authors.lastname: Cavkaytar
authors.forename: M
authors.initials: M
authors.lastname: Doğanay
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000097:blood; D018394:CA-125 Antigen / Q000097:blood*; D004715:Endometriosis / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D013509:Gynecologic Surgical Procedures / Q000379:methods; D006801:Humans; D015994:Incidence; D010535:Laparoscopy / Q000379:methods; D010048:Ovarian Cysts / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology / Q000601:surgery*; D011237:Predictive Value of Tests; D011247:Pregnancy; D011248:Pregnancy Complications / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology / Q000601:surgery*; D011379:Prognosis; D012008:Recurrence; D012086:Reoperation; D012189:Retrospective Studies; D012307:Risk Factors; D012680:Sensitivity and Specificity; D016896:Treatment Outcome; D014421:Turkey / Q000453:epidemiology
chemical_list: D015415:Biomarkers; D018394:CA-125 Antigen